Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Petition for Roundup Ban In Europe Large Enough To Require EU Commission Response June 19, 2017 Irvin Jackson Add Your Comments More than 1 million Europeans have signed a petition calling for a ban on all glyphosate-based pesticides, amid growing concerns about the health risks of Roundup, Monsanto’s popular weed killer, which has been linked to reports of non-Hodgkin’s lymphoma and other forms of cancer. The European Citizens Initiative (ECI) issued a press release (PDF) on June 15, announcing that it had gathered enough signatures to force the European Union’s (EU) Commission to issue a formal response. The group says that the petition gathered signatures faster than any petition since the EU established the petition tool in 2012. The petition to ban Roundup and similar weedkillers has gathered more than one million signatures from EU citizens from all 28 member states in just five months. It calls for a ban of glyphosate, the active ingredient in Roundup, as well as reforms to the EU’s pesticide approval process and calls for targets to reduce the use of pesticide across the European Union. ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Concerns over the link between glyphosate and cancer were raised by the World Health Organization’s International Agency for Research on Cancer (IARC) in March 2015, when glyphosate was classified as a probable human carcinogen. Although Monsanto has attempted to defend the safety of Roundup, one of the most important products for the company, criticizing the IARC’s decision and dismissing safety concerns as agenda driven and based on “junk science,” a number of leading health experts have called for limits on use of the herbicide and safety precautions for those who regularly spray Roundup. The European Food Safety Authority (ESFA) has also contradicted the IARC findings, declaring glyphosate to be safe. However, several countries in the EU have moved to ban glyphosate use, despite the European Commission’s decision to extend the license for glyphosate use for 12 to 18 months in late June 2016. That extension will run out by the end of the year, requiring another vote, and the safety of glyphosate is still heavily debated, with many independent scientists from the EU and the U.S. warning regulators to take the IARC’s cancer concerns seriously. “European citizens aren’t fooled by the pesticide industry’s lobbying efforts or the faulty science it’s peddling,” David Schwartz, an ECI coordinator, said in the press release. “In less than five months, more than one million EU citizens have joined our call for a glyphosate ban and reduced pesticide use throughout the EU. Our politicians need to hear this message loud and clear: they must protect citizens and the environment by banning this dangerous weedkiller and putting us on the path towards a pesticide-free future.” ECI says that the European Commission is expected to issue a formal proposal that would renew the glyphosate license for another 10 years before a meeting with government representatives on July 19 and 20. ECI says that it will submit the petition at the beginning of July. The questions come as Monsanto faces a growing number of Roundup lawsuits filed in the United States by farmers, landscapers and other agricultural workers, each involving claims that exposure to the weedkiller caused the diagnosis of non-Hodgkin’s lymphoma or other forms of cancer. Plaintiffs indicate that the manufacturer knew or should have known about the cancer risks with Roundup, yet withheld important warnings and safety precautions from consumers. A recent U.S. Geological Survey on glyphosate usage nationwide found that an estimated 2.6 billion pounds of the herbicide has been sprayed on America’s agricultural land over the two decades since the mid-1990s, when Monsanto introduced “Roundup Ready” crops that are designed to survive being sprayed with glyphosate, killing the weeds but not the crops. Tags: Cancer, Europe, Glyphosate, Monsanto, Non-Hodgkins Lymphoma, Pesticide, Roundup, Weed Killer Image Credit: Photo Courtesy of <a href="https://www.flickr.com/photos/jeepersmedia/14874003257/in/photolist-oEn9Y2-oEmvHy-bTWHFx-nfCdLV-r4HEKx-rnWS2S-r6sFqE-p2qQKx-oZp21Q-p2arLx-oZoYWu-p2qRNe-oZp1K9-oWzFf8-oJWeBo-oWPq8C-p2oWDC-oJWGji-oEmb2Z-oWRdiz-GJW4pR-GGDZ27-a9RCv2-qrg4mF-rnV1kP-fwZmz-2sscR9-oe3oMa-sboouE-7Q9sz-auohod-rbkbaM-dykaWR-HadKLC-rnUQ6F-r4HT7B-rkKbUm-qr3DSm-qr3t6G-r6sNDC-qr3A3h-9Kvo44-5XtM3N-ey91rF-oe3ovi-8XXkwu-odYLgh-nWy2oy-ofPpbP-odSXiw">Mike Mozart via Flickr</a> Creative Commons More Roundup Lawsuit Stories New Study Appears To Confirm Link Between Roundup and Cancer July 7, 2025 U.S. Supreme Court Invites Government To Weigh In on Roundup Cancer Lawsuits July 1, 2025 Roundup Lawsuit Payout of $611M Upheld by Appeals Court May 29, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025) Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)